Novo Foundation

Novo Foundation is a private Danish philanthropic organization established in 2009 focused on supporting scientific research, public health, climate resilience, and social innovation through grantmaking and programmatic partnerships. It operates across Europe, North America, and the Global South, collaborating with universities, research institutes, hospitals, nonprofits, and intergovernmental organizations. The foundation channels capital into biomedical research, environmental initiatives, and policy advocacy, while engaging with academic publishers, professional societies, and multilateral agencies.

History

The foundation was established in 2009 by heirs to the Novo Nordisk pharmaceutical fortune and incorporated in Denmark with an early emphasis on translational biomedicine and public health. Early partnerships included grants to University of Copenhagen, Karolinska Institutet, Harvard University, and Imperial College London to support translational research, biomedical infrastructure, and clinical trials networks. During the 2010s it expanded into environmental funding, aligning with initiatives led by United Nations Framework Convention on Climate Change, Intergovernmental Panel on Climate Change, and regional programs like the European Green Deal. It has since partnered with global health actors such as World Health Organization and Gavi, the Vaccine Alliance while funding projects with Bill & Melinda Gates Foundation-affiliated researchers and independent NGOs.

Mission and Funding Priorities

The foundation’s publicly stated mission centers on accelerating discovery in life sciences, advancing global health equity, and supporting climate and nature-based solutions. Priority areas listed in grant solicitations include biomedical innovation (supporting work at Massachusetts Institute of Technology, Stanford University, Johns Hopkins University), ecosystem restoration with partners such as IUCN and WWF International, and social interventions tested through trials at institutions like Rand Corporation and London School of Economics. Funding mechanisms span investigator-initiated grants, program-related investments with financial intermediaries such as European Investment Bank affiliates, and collaborative calls coordinated with consortia including Wellcome Trust and Chan Zuckerberg Initiative.

Major Initiatives and Programs

The foundation has funded flagship programs in biomedical research infrastructure, such as creating endowments for translational centers at Rigshospitalet and enabling consortia linking CERN-style data platforms for biomedical data sharing with partners like European Molecular Biology Laboratory and ELIXIR. In global health it supported vaccine delivery pilots co-designed with PATH and health systems strengthening projects in partnership with Médecins Sans Frontières and national ministries of health, often engaging with Global Fund mechanisms. Environmental programs have included rewilding and coastal resilience pilots connected to The Nature Conservancy and regional programs under Convention on Biological Diversity frameworks. The foundation has also invested in science policy and open science initiatives, backing preprint platforms similar to bioRxiv and infrastructure efforts involving CrossRef and ORCID.

Governance and Leadership

Governance is structured around a board of directors and an independent grants advisory committee. Board members have included executives and trustees with backgrounds at institutions such as Novo Nordisk A/S, Carlsberg Foundation, European Commission agencies, and research universities including Technical University of Denmark. Senior leadership has typically comprised executives with prior roles at philanthropic organizations and corporate foundations linked to Novo Nordisk Foundation-adjacent networks, and program directors recruited from National Institutes of Health, Wellcome Trust, and major academic medical centers. The advisory committee draws scientific reviewers from laboratories at University of Oxford, University of California, San Francisco, Pasteur Institute, and policy experts from OECD and World Bank staff.

Controversies and Criticism

Critics have highlighted potential conflicts of interest stemming from historical family ties to the pharmaceutical sector, comparing governance relationships to debates involving Big Pharma and philanthropic influence in science policy, and raising concerns similar to critiques leveled at the Gates Foundation. Academic commentators have questioned funding concentration in elite institutions such as Harvard Medical School and University of Cambridge, arguing this can skew research agendas away from locally led projects in low- and middle-income countries that involve institutions like Makerere University and University of São Paulo. Environmental advocates have sometimes challenged the foundation’s portfolio balance, contrasting support for technological interventions with calls from groups like Friends of the Earth and Greenpeace for stronger community-led conservation. Transparency advocates have pressed for clearer disclosure practices comparable to standards promoted by Transparency International and the Open Society Foundations.

Category:Foundations based in Denmark